2020-09-28T14:16:56-05:00 2019-12-31 521392008 GELMAN ROSENBERG & FREEDMAN 4550 MONTGOMERY AVE SUITE 800N BETHESDA MD 208142930 990 2019-01-01 450672514 USAGAINSTALZHEIMER'S USAG 2024105199 1101 K STREET NW NO 400 WASHINGTON DC 20005 RUSSELL PAULSEN CHIEF OPERATING OFFICER 2024105199 2020-09-28 1 RICHARD J LOCASTRO CPA P00288314 3019519090 75.103.231.202 2020-09-28 15:16:51 ED P 3242370ACE0FDCD1644E50D607094B3FB533101C C2BAA6D0041C88F87D22D64051AEF03C2A501AAC 2019 2021-01-29 14:40:06Z RUSSELL PAULSEN 1101 K STREET NW NO 400 WASHINGTON DC 20005 8119043 0 X WWW.USAGAINSTALZHEIMERS.ORG X 2011 DC SEE PART III, LINE 1. 10 7 12 20 0 0 7246101 8043581 238430 0 4651 9425 0 -263978 7489182 7789028 369070 327909 0 0 642876 1325513 0 0 667356 7248843 6494962 8260789 8148384 -771607 -359356 5006152 5047065 391566 791835 4614586 4255230 X USAGAINSTALZHEIMER'S, AN INNOVATIVE, PATIENT-CENTERED NON-PROFIT, DEMANDS GREATER URGENCY FROM GOVERNMENT, INDUSTRY, AND THE RESEARCH COMMUNITY TO EFFECTIVELY TREAT, PREVENT AND ULTIMATELY CURE ALZHEIMER'S DISEASE. (CONTINUED ON SCHEDULE O) 0 0 6941823 327909 USAGAINSTALZHEIMER'S HAS WORKED ACROSS SECTORS TO ACHIEVE IMPORTANT MILESTONES, INCLUDING:- SECURING THE U.S. GOAL OF PREVENTING AND EFFECTIVELY TREATING ALZHEIMER'S BY 2025 THROUGH THE NATIONAL ALZHEIMER'S PLAN, AND DRIVING GLOBAL EFFORTS THAT LED THE WORLD'S MOST POWERFUL NATIONS, THE G7, TO EMBRACE A SIMILAR 2025 GOAL.- HELPING TO SHOW THE IMPORTANCE OF GREATER U.S. INVESTMENT IN DEMENTIA RESEARCH AT NATIONAL INSTITUTES OF HEALTH (NIH) TO IMPROVE THE SCIENTIFIC KNOWLEDGE ABOUT THE DISEASE AND POTENTIAL TREATMENT PATHS. - DRIVING GLOBAL ACTION AGAINST DEMENTIA, (CONTINUED ON SCHEDULE O)WE BEGAN WORK TO LAUNCH A PARTNERSHIP WITH THE WORLD ECONOMIC FORUM TO CREATE A MULTI-YEAR, GLOBAL EFFORT TO ACCELERATE ALZHEIMER'S CURES THAT IS MODELED ON GLOBAL FUNDING MECHANISMS FOR INFECTIOUS DISEASES AND FOR VACCINE ACCELERATION.- DOCUMENTING THE NEED FOR HEALTH EQUITY AND ACCESS FOR COMMUNITIES OF COLOR AND FOR WOMEN, IN 2019 WE COMPLETED THE FIRST PHASE OF THE NATIONAL ALZHEIMER'S DISEASE INDEX, A NEW PLATFORM THE ENABLES RESEARCHERS AND POLICYMAKERS TO SEE DISPARITIES IN ALZHEIMER'S PREVALENCE AND COST AT THE ZIP CODE LEVEL. THIS ADVANCES OUR WORK AS THE LEADING VOICE FOR HEALTH EQUITY AND ACCESS TO CARE, TREATMENTS, AND RESEARCH FOR UNDERSERVED COMMUNITIES. - CONDUCTING RESEARCH ON WHAT MATTERS MOST TO PEOPLE LIVING WITH THE DISEASE AND THEIR CAREGIVERS THAT CAN BE USED TO INFORM DRUG DEVELOPMENT AND POLICY ACTIONS. OUR GROUND-BREAKING PATIENT AND CAREGIVER-LED COLLABORATION OF INDUSTRY, ACADEMICS, GOVERNMENT AGENCIES AND ADVOCATES IS BUILDING A PLATFORM TO DELIVER NEW INSIGHTS TO RESEARCH, REGULATORY AND PAYER AUTHORITIES ON PREFERRED TREATMENT AND HEALTH OUTCOMES SOUGHT BY THOSE LIVING WITH ALZHEIMER'S AND THEIR CAREGIVERS. - RELEASING "A CALL FOR ACTION: CREATING AN OPTIMAL SYSTEM OF BRAIN HEALTH CARE IN THE UNITED STATES," A WHITE PAPER WHICH ARTICULATED A BRAIN HEALTH STANDARD OF CARE AND PROVIDED A ROADMAP ABOUT HOW TO MAKE IT A REALITY. THIS PAPER IS PART OF OUR BRAIN HEALTH PARTNERSHIP, AN INITIATIVE TO ENSURE BRAIN HEALTH IS INCLUDED AS AN INTEGRAL ELEMENT OF OVERALL GOOD HEALTH AND COGNITIVE DECLINE IS IDENTIFIED AND ADDRESSED IN A TIMELY MANNER.- RAISING PUBLIC AWARENESS OF ALZHEIMER'S, BRAIN HEALTH, EQUITABLE ACCESS AND THE IMPORTANCE OF RESEARCH AND EARLY DETECTION VIA MAJOR MEDIA NEWS COVERAGE IN OUTLETS SUCH AS "TODAY", NEW YORK TIMES, WALL STREET JOURNAL, USA TODAY, WASHINGTON POST, FORBES, REUTERS, WOMEN'S HEALTH, ROLL CALL, PBS, CLEVELAND PLAIN DEALER.- ENGAGING THROUGH OUR NETWORKS THOSE MOST AFFECTED: AFRICAN AMERICANS AND LATINOS TO FIGHT ALZHEIMER'S DISPARITIES AND LOW RESEARCH PARTICIPATION; WOMEN THROUGH A TARGETED EDUCATIONAL CAMPAIGN (SEX-BASED RESEARCH, CAREGIVER SUPPORT); THE FAITH COMMUNITY TO INFORM AND ENGAGE THEIR MEMBERS; AND VETERANS TO RAISE RESEARCH PARTICIPATION AND AWARENESS OF ALZHEIMER'S AS AN URGENT HEALTH ISSUE. NOTE: IN MANY CASES, USAGAINSTALZHEIMER'S CONTRACTS WITH FIRMS TO PROVIDE CORE CAPACITIES, INCLUDING POLICY, COMMUNICATIONS AND MEDIA, AND DIGITAL MARKETING, AS WELL AS TO LEAD SEVERAL OF OUR PROGRAMS. 6941823 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 1 1 0 0 1 0 0 1 0 1 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 1 59 0 1 12 1 0 0 0 0 0 0 0 0 0 0 0 0 X 10 7 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 AL AR CA FL GA HI IL KS KY ME MD MA MI MN MS NH NJ NM NY NC OR PA RI SC TN UT VA WV WI X RUSSELL PAULSEN 2024105199 1101 K STREET NW SUITE 400 WASHINGTON DC 20005 X GEORGE VRADENBURG CHAIRMAN 30.00 X X 0 0 0 SHAWN TAYLOR TREASURER 1.00 X X 0 0 0 KAREN SEGAL SECRETARY 4.00 X X 0 0 0 MERYL COMER FOUNDING BOARD MEMBER (SEE SCH. O) 40.00 X 214000 0 0 JOHN DWYER BOARD MEMBER 2.00 X 0 0 0 PETER LEVIN BOARD MEMBER (UNTIL 9/2019) 1.00 X 0 0 0 STANLEY PRUSINER BOARD MEMBER 0.10 X 0 0 0 DAVID SATCHER BOARD MEMBER 2.00 X 0 0 0 GREG O'BRIEN BOARD MEMBER (SEE SCH. O) 2.00 X 11112 0 0 WILLIAM VEGA BOARD MEMBER 2.00 X 0 0 0 DREW HOLZPAFEL BD. MEM./INTERIM PRES (UNTIL 6/2019) 5.00 X 0 0 0 MARILYN GLOSSERMAN BOARD MEMBER 2.00 X 0 0 0 RUSSELL PAULSEN COO (FROM 5/2019) 35.00 X 129561 0 77 M'LISS REINGRUBER CHIEF FINANCIAL OFFICER 35.00 X 150000 0 98 JASON RESENDEZ COS, PROGRAM DIRECTOR 38.00 X 193000 0 98 STEPHANIE MONROE PROGRAM DIRECTOR 40.00 X 175000 0 98 VIRGINIA BIGGAR PROGRAM DIRECTOR 35.00 X 147000 0 98 CRAIG DOANE CDO (UNTIL 12/2019) 40.00 X 195873 0 6601 1215546 0 7070 7 0 1 0 FAEGRE DRINKER BIDDLE & REATH LLP 200 WF CTR 90 S 7 ST MINNEAPOLIS MN 55402 FEDERAL POLICY /AWARENESS 1026299 HIGH LANTERN GROUP 685 THIRD AVE 22ND FLOOR NEW YORK NY 10017 PROGRAM STRATEGY/MGMT 952690 RTI HEALTH SOLUTIONS PO BOX 12194 RESEARCH TRIANGLE PARK NC 27709 PROGRAM CONSULTING 599422 RATIONAL 360 1828 L ST NW STE 640 WASHINGTON DC 20036 DIGITAL COMM./SOCIAL MEDIA 543834 IAN N KREMER 2920 PARKLAWN CT HERNDON VA 20171 PROGRAM STRATEGY/MGMT 317300 10 785000 318531 6940050 70703 8043581 10758 10758 55154 56487 -1333 -1333 -1333 9550 318531 273528 -263978 -263978 7789028 0 0 -254553 X 277107 277107 50802 50802 327405 299054 28351 879220 461643 269357 148220 33234 20928 6310 5996 85654 53962 16274 15418 62603 62603 93161 54888 38273 5742058 5368598 30558 342902 3000 3000 45555 18817 20522 6216 70583 48982 10831 10770 45885 28908 8718 8259 74483 36320 19250 18913 324807 270578 1400 52829 4259 4259 PAYROLL FEES 30970 19511 5884 5575 STATE REGISTRATION FEES 13985 13985 MISCELLANEOUS -16387 -16387 8148384 6941823 539205 667356 2708716 3131356 510487 695740 1272714 885070 482453 302948 26575 23251 5207 8700 5006152 5047065 375177 591835 200000 16389 0 391566 791835 X 1043920 610027 3570666 3645203 4614586 4255230 5006152 5047065 -359356 0 X 0 1 X 1 0 X 6826699 5654618 9733989 7246101 8043581 37504988 6826699 5654618 9733989 7246101 8043581 37504988 6764673 30740315 4808 10758 15566 37520554 304430 0.81930 0.79690 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 X 8062556 0 8062556 -273528 -273528 7789028 8421912 0 8421912 -273528 -273528 8148384 PART X, LINE 2: FOR THE YEAR ENDED DECEMBER 31, 2019, USA2 HAS DOCUMENTED THEIR CONSIDERATION OF FASB ASC 740-10, INCOME TAXES, THAT PROVIDES GUIDANCE FOR REPORTING UNCERTAINTY IN INCOME TAXES AND HAS DETERMINED THAT NO MATERIAL UNCERTAIN TAX POSITIONS QUALIFY FOR EITHER RECOGNITION OR DISCLOSURE IN THE COMBINED FINANCIAL STATEMENTS. PART XI, LINE 4B - OTHER ADJUSTMENTS: FUNDRAISING EVENT EXPENSES REPORTED AS AN EXPENSE IN THE AUDITED FINANCIAL STATEMENTS AND NETTED AGAINST EVENT INCOME ON FORM 990, PART VIII, LINE 8C. -273,528. PART XII, LINE 4B - OTHER ADJUSTMENTS: FUNDRAISING EVENT EXPENSES REPORTED AS AN EXPENSE IN THE AUDITED FINANCIAL STATEMENTS AND NETTED AGAINST EVENT INCOME ON FORM 990, PART VIII, LINE 8C. -273,528. 1 EUROPE 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 50802 0 0 0 0 0 0 50802 0 50802 EUROPE GRANTS TO SUPPORT CLINICAL RESEARCH 45709 WIRE EUROPE EVENT SPONSORSHIP 5093 WIRE 2 0 1 0 0 0 0 0 PART I, LINE 2: GENERAL SUPPORT GRANTS ARE MONITORED VIA PROGRESS REPORTS AND IN-PERSON MEETINGS TO DISCUSS RESEARCH FINDINGS. PART III ACCOUNTING METHOD: DINNER 328081 318531 9550 14216 47495 89679 22700 99438 328081 318531 9550 14216 47495 89679 22700 99438 273528 -263978 1 ALZHEIMER'S DRUG DISCOVERY FOUNDATION 57 WEST 57TH STREET SUITE 904 NEW YORK NY 10019 201082179 501(C)(3) 5000 EVENT SPONSORSHIP BRIGHTFOCUS FOUNDATION 22512 GATEWAY CENTER DR CLARKSBURG MD 20871 277337229 501(C)(3) 10000 EVENT SPONSORSHIP DUKE UNIVERSITY 324 BLACKWELL ST DURHAM NC 27701 560532129 501(C)(3) 100000 SUPPORT RESEARCH IN DEVELOPING A PATH TO ENHANCE QUALITY OF CARE FOR ALZHEIMERS PATIENTS FOUNDATION FOR THE NIH 11400 ROCKVILLE PIKE SUITE 600 BETHESDA MD 20852 521986675 501(C)(3) 10000 EVENT SPONSORSHIP N4ADEMENTIA FRIENDLY AMERICA INITIATIVE 1730 RHODE ISLAND AVE NW SUITE 1200 1200 WASHINGTON DC 20036 521052345 501(C)(3) 12500 SUPPORT OF DEMENTIA FRIENDLY AMERICA INITIATIVE GLOBAL COALITION ON AGING LLC 685 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017 274118914 N/A 30000 EVENT SPONSORSHIP RESEARCH AMERICA 241 18TH ST NW SOUTH 501 ARLINGTON VA 22202 521609875 501(C)(3) 15000 EVENT SPONSORSHIP VOLUNTEERS OF AMERICA 1660 DUKE STREET ALEXANDRIA VA 22314 131692595 501(C)(3) 5000 EVENT SPONSORSHIP THE MILKEN INSTITUTE 1250 FOURTH STREET SANTA MONICA CA 90401 954240775 501(C)(3) 25000 EVENT SPONSORSHIP THE YOUTH MOVEMENT AGAINST ALZHEIMER'S 10000 WASHINGTON BLVD CULVER CITY CA 90232 208083398 501(C)(3) 5000 EVENT SPONSORSHIP MASS GENERAL HOSPITAL PSYCHIATRY ACADEMY 125 NASHUA ST SUITE 540 BOSTON MA 02114 041564655 501(C)(3) 5000 EVENT SPONSORSHIP 10 1 PART I, LINE 2: EVENT SPONSORSHIPS WERE NOT MONITORED AFTER AWARD. USA2 HAD REPRESENTATIVES ATTEND THE EVENTS. GENERAL SUPPORT GRANTS ARE MONITORED VIA PROGRESS REPORTS AND IN-PERSON MEETINGS TO DISCUSS RESEARCH FINDINGS. X X X 1 0 0 0 0 0 0 0 0 MERYL COMER FOUNDING BOARD MEMBER (SEE SCH. O) 214000 0 0 0 0 0 0 0 0 0 214000 0 0 0 M'LISS REINGRUBER CHIEF FINANCIAL OFFICER 150000 0 0 0 0 0 0 0 98 0 150098 0 0 0 JASON RESENDEZ COS, PROGRAM DIRECTOR 193000 0 0 0 0 0 0 0 98 0 193098 0 0 0 STEPHANIE MONROE PROGRAM DIRECTOR 175000 0 0 0 0 0 0 0 98 0 175098 0 0 0 CRAIG DOANE CDO (UNTIL 12/2019) 179206 0 0 0 16667 0 0 0 6601 0 202474 0 0 0 PART I, LINE 4A CRAIG DOANE, CDO, RECEIVED A SERVERANCE PAYMENT AND ACCRUED PTO PAYOUT OF $12,500 AND $4,167 RESPECTIVELY. THE GEORGE A VRADENBURG III TRUST GEORGE VRADENBURG IS USA2'S CHAIRMAN TO HELP MANAGE CASH FLOW AT THE END OF THE YEAR X 200000 200000 0 1 1 200000 X 8 56487 FMV X DOOR PRIZES 8 14216 FMV 0 0 0 0 PART I, COLUMN (B): THIS COLUMN REPORTS THE NUMBER OF CONTRIBUTORS. FORM 990, PART III, LINE 1, DESCRIPTION OF ORGANIZATION MISSION: WE WORK TO ACCOMPLISH THIS THROUGH EFFECTIVE LEADERSHIP, COLLABORATION AND STRATEGIC INVESTMENTS - ALL GUIDED AND INFORMED BY THE PERSPECTIVES OF PEOPLE LIVING WITH THE DISEASE AND THEIR CAREGIVERS. THROUGH NETWORKS AND COALITIONS, WE ENGAGE THE MOST DEEPLY AFFECTED COMMUNITIES (WOMEN, AFRICAN AMERICANS, LATINOS, PATIENTS, CAREGIVERS, VETERANS, CLERGY, AND RESEARCHERS) TO: - FOCUS ATTENTION ON THE UNIQUE BURDEN OF ALZHEIMER'S ON WOMEN AND COMMUNITIES OF COLOR, GIVEN THE DISPARATE IMPACT OF THE DISEASE ON THESE COMMUNITIES. - GIVE GREATER VOICE TO INDIVIDUALS LIVING WITH ALZHEIMER'S AND RELATED DEMENTIAS -AND THEIR CAREGIVERS-IN SCIENTIFIC AND REGULATORY DECISIONS. - INCREASE THE SPEED, EFFICIENCY OF AND PARTICIPATION IN CLINICAL RESEARCH. - ENSURE THAT CONSUMERS, HEALTHCARE PROVIDERS, AND POLICYMAKERS TREAT BRAIN HEALTH AS AN INTEGRAL ELEMENT OF OVERALL GOOD HEALTH AND SEE THE IMPORTANCE OF IDENTIFYING COGNITIVE DECLINE EARLY. - ALLEVIATE THE ECONOMIC AND HUMAN BURDENS OF CAREGIVING THROUGH FAMILY-FRIENDLY FEDERAL AND WORKPLACE POLICIES, SUCH AS PAID FAMILY AND MEDICAL LEAVE FOR ALZHEIMER'S AND DEMENTIA CAREGIVERS. OUR THEORY OF CHANGE IS BASED ON THE BELIEF THAT IT WILL TAKE ALL OF "US" TO ADDRESS A MAJOR HEALTH CHALLENGE LIKE ALZHEIMER'S. THIS MEANS CROSS-SECTOR COLLABORATION AROUND COMMON GOALS AND INITIATIVES. IT MEANS BEING NIMBLE AND RESPONSIVE TO PARTNERS, COMMUNITIES, POLICYMAKERS, AND THE CHANGING HEALTHCARE LANDSCAPE. COLLABORATION IS A CORE PART OF THE DNA OF USAGAINSTALZHEIMER'S AND CENTRAL TO OUR THEORY OF CHANGE. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 WAS PREPARED BY THE OUTSIDE ACCOUNTANTS AND REVIEWED BY ONE OF THE DIRECTORS AND THE CHIEF FINANCIAL OFFICER. A COPY OF THE FORM 990 WAS PROVIDED TO THE ORGANIZATION'S GOVERNING BODY BEFORE IT WAS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C EACH DIRECTOR, PRINCIPAL OFFICER AND MEMBER OF A COMMITTEE WITH GOVERNING BOARD DELEGATED POWERS ANNUALLY SIGNS A STATEMENT WHICH AFFIRMS THAT EACH HE/SHE: A. HAS RECEIVED A COPY OF THE CONFLICTS OF INTEREST POLICY, B. HAS READ AND UNDERSTANDS THE POLICY, C. HAS AGREED TO COMPLY WITH THE POLICY, AND D. UNDERSTANDS THAT THE ORGANIZATION IS A NON-PROFIT PUBLIC BENEFIT CORPORATION AND, IN ORDER TO MAINTAIN ITS FEDERAL TAX EXEMPTION, IT MUST ENGAGE PRIMARILY IN ACTIVITIES WHICH ACCOMPLISH ONE OR MORE OF ITS TAX-EXEMPT PURPOSES. IN CONNECTION WITH ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE OF THE FINANCIAL INTEREST AND BE GIVEN THE OPPORTUNITY TO DISCLOSE ALL MATERIAL FACTS TO THE DIRECTORS AND MEMBERS OF COMMITTEES WITH GOVERNING BOARD DELEGATED POWERS CONSIDERING THE PROPOSED TRANSACTION OR ARRANGEMENT. AFTER DISCLOSURE OF THE FINANCIAL INTEREST AND ALL MATERIAL FACTS, AND AFTER ANY DISCUSSION WITH THE INTERESTED PERSON, HE/SHE LEAVES THE GOVERNING BOARD OR COMMITTEE MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON. THE REMAINING BOARD OR COMMITTEE MEMBERS DECIDE IF A CONFLICT OF INTEREST EXISTS. FORM 990, PART VI, SECTION B, LINE 15A COMPENSATION IS DISCUSSED WITH THE BOARD CHAIRMAN, WHO USES INFORMATION FROM A REVIEW OF COO COMPENSATION AT OTHER NON-PROFITS, AND A PERFORMANCE REVIEW IS CONDUCTED. THE COMPENSATION IS THEN APPROVED BY THE BOARD WHEN IT APPROVES THE BUDGET. THE MOST RECENT COMPENSATION REVIEW TOOK PLACE IN DECEMBER 2019. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART VII, LINE 1: USAGAINSTALZHEIMER'S (USA2) AND USAGAINSTALZHEIMER'S ACTION (USA2ACTION), AN UNRELATED ORGANIZATION FOR TAX PURPOSES, HAVE ENTERED INTO A COST-SHARING ARRANGEMENT UNDER WHICH USA2ACTION REIMBURSES USA2 FOR USA2ACTION'S ALLOCABLE SHARE OF THE COMPENSATION OF CERTAIN EMPLOYEES FOR SERVICES PROVIDED TO USA2ACTION. PURSUANT TO THIS AGREEMENT, USA2ACTION REIMBURSED USA2 FOR ITS SHARE OF OFFICER COMPENSATION AS FOLLOWS: RUSSELL PAULSEN: $16,233 FORM 990, PART VII, LINE 1: MERYL COMER RECEIVED COMPENSATION FOR HER WORK AS A SENIOR PROJECT ADVISOR. HER COMPENSATION IS UNRELATED TO HER DUTIES AS A BOARD MEMBER. GREG O'BRIEN RECEIVED COMPENSATION FOR HIS WORK AS AN ADVOCATE AND COMMUNICATIONS CONSULTANT. HIS COMPENSATION IS UNRELATED TO HIS DUTIES AS A BOARD MEMBER. FORM 990, PART IX, LINE 11G PROGRAM MANAGEMENT/STRATEGY: PROGRAM SERVICE EXPENSES 1,819,786. MANAGEMENT AND GENERAL EXPENSES 11,273. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,831,059. PROJECT FUNDS: PROGRAM SERVICE EXPENSES 2,804,489. MANAGEMENT AND GENERAL EXPENSES 4,076. FUNDRAISING EXPENSES 218,484. TOTAL EXPENSES 3,027,049. COMMUNICATIONS: PROGRAM SERVICE EXPENSES 588,961. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 17,981. TOTAL EXPENSES 606,942. OTHER PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 155,362. MANAGEMENT AND GENERAL EXPENSES 15,209. FUNDRAISING EXPENSES 106,437. TOTAL EXPENSES 277,008. FORM 990, PART IX, LINE 11G: FOR MANY SERVICES, USA2 CONTRACTS WITH FIRMS TO PROVIDE CORE CAPACITIES, INCLUDING POLICY/LEGISLATIVE AFFAIRS, COMMUNICATIONS AND MEDIA, DIGITAL MARKETING, AND TO LEAD TWO OF OUR CORE NETWORKS (RESEARCHERSAGAINSTALZHEIMER'S AND WOMENAGAINSTALZHEIMER'S).